{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:21:32Z","timestamp":1772792492382,"version":"3.50.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science of Republic of Serbia","award":["175033"],"award-info":[{"award-number":["175033"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.beem.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T19:46:35Z","timestamp":1487792795000},"page":"35-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Controversies in the risk of neoplasia in GH deficiency"],"prefix":"10.1016","volume":"31","author":[{"given":"Sandra","family":"Pekic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.beem.2017.02.004_bib1","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2017.02.004_bib2","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12020-015-0840-2","article-title":"Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician","volume":"52","author":"Yuen","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.02.004_bib4","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib6","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib9","first-page":"659","article-title":"Incidence of a second tumor in hypopituitary patients operated for pituitary tumors","volume":"86","author":"Erfurth","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism, West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.beem.2017.02.004_bib11","first-page":"1420","article-title":"Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality","volume":"85","author":"Nilsson","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2017.02.004_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1507\/endocrj.EJ15-0337","article-title":"Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]","volume":"62","author":"Giovannini","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2017.02.004_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-78818-0_6","article-title":"Obesity and diabetes epidemics: cancer repercussions","volume":"630","author":"Hjartaker","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"14","key":"10.1016\/j.beem.2017.02.004_bib14","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.ejca.2010.07.052","article-title":"Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe","volume":"46","author":"Renehan","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1634\/theoncologist.2015-0351","article-title":"Obesity and breast cancer: molecular interconnections and potential clinical applications","volume":"21","author":"Simone","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.beem.2017.02.004_bib16","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1158\/1078-0432.CCR-04-1868","article-title":"Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance","volume":"11","author":"Otake","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.beem.2017.02.004_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/er.2004-0022","article-title":"The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults","volume":"27","author":"Woodhouse","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.02.004_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/1756-0500-7-813","article-title":"Impact of adult growth hormone deficiency on daily functioning and well-being","volume":"7","author":"Brod","year":"2014","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.beem.2017.02.004_bib19","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ijc.29953","article-title":"Sedentary behaviors and light-intensity activities in relation to colorectal cancer risk","volume":"138","author":"Keum","year":"2016","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.beem.2017.02.004_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1158\/1055-9965.EPI-15-0237","article-title":"Leisure-time spent sitting and site-specific cancer incidence in a large U.S. Cohort","volume":"24","author":"Patel","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"10.1016\/j.beem.2017.02.004_bib21","first-page":"1691","article-title":"Moderate-to-vigorous physical activity and leisure-time sitting in relation to ovarian cancer risk in a large prospective US cohort","volume":"26","author":"Hildebrand","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.beem.2017.02.004_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/1940-6207.CAPR-15-0291","article-title":"Uninterrupted sedentary behavior downregulates BRCA1 gene expression","volume":"9","author":"Pettapiece-Phillips","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.beem.2017.02.004_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-14-0172","article-title":"Alterations in diurnal rhythmicity in patients treated for nonfunctioning pituitary macroadenoma: a controlled study and literature review","volume":"171","author":"Joustra","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2017.02.004_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00420-014-0986-x","article-title":"Circadian disrupting exposures and breast cancer risk: a meta-analysis","volume":"88","author":"He","year":"2015","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.beem.2017.02.004_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.25507","article-title":"Short duration of sleep increases risk of colorectal adenoma","volume":"15","author":"Thompson","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib26","first-page":"230","article-title":"Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents","volume":"70","author":"Lanes","year":"2008","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2017.02.004_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2265.2003.01832.x","article-title":"Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness","volume":"59","author":"Leonsson","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/jc.2002-020470","article-title":"Induction of postprandial inflammatory response in adult onset growth hormone deficiency is related to plasma remnant-like particle-cholesterol concentration","volume":"88","author":"Twickler","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12885-016-2115-6","article-title":"Inflammatory biomarker score and cancer: a population-based prospective cohort study","volume":"16","author":"Morrison","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3945\/ajcn.112.039438","article-title":"Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malm\u00f6 diet and cancer cohort","volume":"96","author":"Drake","year":"2012","journal-title":"Am J Nutr"},{"key":"10.1016\/j.beem.2017.02.004_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.psyneuen.2012.09.008","article-title":"Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy","volume":"38","author":"Holmer","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.beem.2017.02.004_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1507\/endocrj.49.597","article-title":"Adult growth hormone deficiency in Japan: results of investigation by questionnaire","volume":"49","author":"Kaji","year":"2002","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2017.02.004_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12020-015-0670-2","article-title":"Subjects with isolated GH deficiency due to a null GHRHR mutation eat proportionally more, but healthier than controls","volume":"51","author":"Oliveira-Santos","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.02.004_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bju.13417","article-title":"Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate specific antigen (PSA): a meta-analysis","volume":"118","author":"Boyle","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.beem.2017.02.004_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AOG.0b013e31825a717b","article-title":"Postoophorectomy estrogen use and breast cancer risk","volume":"120","author":"Nichols","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.beem.2017.02.004_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1677\/ERC-06-0008","article-title":"Incidence and familial risks in pituitary adenoma and associated tumors","volume":"14","author":"Hemminki","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib37","first-page":"527","article-title":"Descriptive epidemiology of pituitary tumors in the United States, 2004-2009","volume":"121","author":"Gittleman","year":"2014","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2017.02.004_bib38","doi-asserted-by":"crossref","first-page":"xv","DOI":"10.1016\/j.ecl.2012.04.021","article-title":"Insulin-like growth factors in health and disease","volume":"41","author":"Perks","year":"2012","journal-title":"Pref Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2017.02.004_bib39","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1038\/srep12891","article-title":"Population landscape of familial cancer","volume":"5","author":"Frank","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2017.02.004_bib40","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib41","first-page":"357","article-title":"Longevity of the hypopituitary patients from the island Krk: a follow-up study","volume":"7","author":"Krzisnik","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.beem.2017.02.004_bib42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4158\/EP15939.RA","article-title":"Lessons from 50 years of study of Laron syndrome","volume":"21","author":"Laron","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2017.02.004_bib43","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1210\/jc.2002-021938","article-title":"Reduced longevity in untreated patients with isolated growth hormone deficiency","volume":"88","author":"Besson","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/jc.2009-1879","article-title":"Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene","volume":"95","author":"Aguiar-Oliveira","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.004_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib47","doi-asserted-by":"crossref","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beem.2017.02.004_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-016-0868-y","article-title":"Cancerous leptomeningitis and familial congenital hypopituitarism","volume":"52","author":"Vujovic","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.02.004_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MED.0b013e328363183a","article-title":"Growth hormone and cancer: an update on progress","volume":"20","author":"Perry","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2017.02.004_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/gerona\/58.4.B291","article-title":"Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity","volume":"58","author":"Ikeno","year":"2003","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.beem.2017.02.004_bib51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/gerona\/59.12.1244","article-title":"Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant","volume":"59","author":"Vergara","year":"2004","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.beem.2017.02.004_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/gerona\/glp017","article-title":"Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor\/binding protein knockout mice","volume":"64","author":"Ikeno","year":"2009","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.beem.2017.02.004_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-004-9504-2","article-title":"Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments","volume":"87","author":"Thordarson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.beem.2017.02.004_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.02.004_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ghir.2012.09.003","article-title":"The role of the insulin-like growth factor-I receptor in malignancy: an update","volume":"22","author":"Seccareccia","year":"2012","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.004_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygcen.2015.06.011","article-title":"Growth hormone and cancer: GH production and action in glioma?","volume":"220","author":"Lea","year":"2015","journal-title":"Gen. Comp Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"Key","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2017.02.004_bib59","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.02.004_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/0008-5472.CAN-11-1601","article-title":"Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT","volume":"72","author":"Rowlands","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2017.02.004_bib61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/bjc.2014.566","article-title":"Insulin-like growth factor I andriskofepithelialinvasiveovariancancerby tumour characteristics: results from the EPIC cohort","volume":"112","author":"Ose","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000438652","article-title":"Circulating insulin-like growth Factor-1 level and ovarian cancer risk","volume":"38","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.beem.2017.02.004_bib63","first-page":"1","article-title":"Growth hormone replacement in patients with a history of malignancy: a review of the literature and best practice for offering treatment","author":"Yuen","year":"2014","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib64","first-page":"6237","article-title":"Growth inhibition of human breast cancer cells in\u00a0vitro with an antibody against the type I somatomedin receptor","volume":"49","author":"Arteaga","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2017.02.004_bib65","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1038\/srep06855","article-title":"Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2017.02.004_bib66","first-page":"3353","article-title":"A\u00a0dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer","volume":"58","author":"Dunn","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2017.02.004_bib67","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/djs258","article-title":"Insulin-like growth factor receptor inhibitors: baby or the bathwater?","volume":"104","author":"Yee","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.beem.2017.02.004_bib68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5732\/cjc.012.10263","article-title":"IGF-1R as an anti-cancer target\u2013trials and tribulations","volume":"32","author":"Chen","year":"2013","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2015.07.026","article-title":"The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer","volume":"367","author":"Heidegger","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2017.02.004_bib70","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-13-0389","article-title":"GH and cancer risk in hypopituitarism: what we know from human studies","volume":"169","author":"Pekic","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib71","first-page":"73","article-title":"Acromegaly and neoplasia","volume":"6","author":"Bengtsson","year":"1993","journal-title":"J\u00a0Pediatr Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib72","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1210\/jcem.86.7.7634","article-title":"Clinical perspective: acromegaly and cancer: a problem","volume":"86","author":"Jenkins","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib73","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2265.2001.01355.x","article-title":"Screening colonoscopy for acromegaly in perspective","volume":"55","author":"Renehan","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.004_bib75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","article-title":"Clinical, quality of life, and economic value of acromegaly disease control","volume":"14","author":"Ben-Shlomo","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.004_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.1997.1911029.x","article-title":"Acromegaly, colonic polyps and carcinoma","volume":"47","author":"Jenkins","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib77","first-page":"152049","article-title":"Increased prevalence of colorectal polyp in acromegaly patients: a case-control study","author":"Koksal","year":"2014","journal-title":"Diagn Ther Endosc"},{"key":"10.1016\/j.beem.2017.02.004_bib78","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11102-014-0580-y","article-title":"The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study","volume":"18","author":"Yamamoto","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.004_bib80","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the German acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib81","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S0004-27302013000900003","article-title":"Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center","volume":"57","author":"Uchoa","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2017.02.004_bib82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","article-title":"Increased thyroid cancer risk in acromegaly","volume":"17","author":"Dagdelen","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.004_bib83","doi-asserted-by":"crossref","first-page":"e104174","DOI":"10.1371\/journal.pone.0104174","article-title":"Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?","volume":"9","author":"Reverter","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2017.02.004_bib84","doi-asserted-by":"crossref","first-page":"e88787","DOI":"10.1371\/journal.pone.0088787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly\u2013meta-analysis and systematic review","volume":"9","author":"Wolinski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.beem.2017.02.004_bib85","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib86","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpeds.2010.02.028","article-title":"Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database)","volume":"157","author":"Wilton","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2017.02.004_bib87","first-page":"1416","article-title":"Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone","volume":"80","author":"Tuffli","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib88","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","article-title":"Risk of leukemia in children treated with human growth hormone: review and reanalysis","volume":"131","author":"Allen","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2017.02.004_bib89","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A\u00a0prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"G\u00f6therstr\u00f6m","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib90","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status\u20133-year results from the HypoCCS Database","volume":"87","author":"Attanasio","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib91","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1530\/eje.0.148s009","article-title":"Long-term experience with GH replacement therapy: efficacy and safety","volume":"148","author":"Monson","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib92","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1210\/jc.2010-0287","article-title":"Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database)","volume":"95","author":"Popovic","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-11-0286","article-title":"Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study","volume":"165","author":"Child","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib94","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.02.004_bib95","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib96","first-page":"75","article-title":"Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem","volume":"31","author":"Losa","year":"2008","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.004_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12477","article-title":"Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity","volume":"81","author":"van Bunderen","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib98","first-page":"4444","article-title":"Growth hormone treatment of children with brain tumors and risk of tumor recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib99","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study","volume":"172","author":"Child","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib101","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-09-0572","article-title":"Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy","volume":"161","author":"Olsson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib102","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2015-1764","article-title":"Tumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy","volume":"100","author":"van Varsseveld","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000207607","article-title":"Hypopituitarism following radiotherapy revisited","volume":"15","author":"Darzy","year":"2009","journal-title":"Endocr Dev"},{"key":"10.1016\/j.beem.2017.02.004_bib104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2017.02.004_bib105","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2017.02.004_bib106","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnci\/93.8.618","article-title":"Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study","volume":"93","author":"Neglia","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.beem.2017.02.004_bib107","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.2011.34.6585","article-title":"Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"29","author":"Armstrong","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2017.02.004_bib108","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of neoplasia in pediatric patients receiving growth hormone therapy - a report from the Pediatric Endocrine Society Drug and Therapeutics Committee","volume":"100","author":"Raman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.004_bib109","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/EJE-12-0967","article-title":"Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.004_bib110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2011.11.022","article-title":"Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study","volume":"84","author":"Henderson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beem.2017.02.004_bib111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11764-013-0292-8","article-title":"Risk of subsequent malignancies in survivors of childhood leukemia","volume":"7","author":"Perkins","year":"2013","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.beem.2017.02.004_bib112","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.28991","article-title":"Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature","volume":"135","author":"Choi","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2017.02.004_bib113","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40618-014-0179-1","article-title":"GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution","volume":"38","author":"Brignardello","year":"2015","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.004_bib114","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","article-title":"Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort","volume":"27","author":"Meadows","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2017.02.004_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/2054270414524567","article-title":"Meningiomas occurring during long-term survival after treatment for childhood cancer","volume":"5","author":"Sugden","year":"2014","journal-title":"JRSM Open"},{"key":"10.1016\/j.beem.2017.02.004_bib116","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:52:28Z","timestamp":1761497548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521690X17300040"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in the risk of neoplasia in GH deficiency","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}